CN114364678A - Compound and organic light emitting device including the same - Google Patents

Compound and organic light emitting device including the same Download PDF

Info

Publication number
CN114364678A
CN114364678A CN202080061153.0A CN202080061153A CN114364678A CN 114364678 A CN114364678 A CN 114364678A CN 202080061153 A CN202080061153 A CN 202080061153A CN 114364678 A CN114364678 A CN 114364678A
Authority
CN
China
Prior art keywords
substituted
chemical formula
group
unsubstituted
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080061153.0A
Other languages
Chinese (zh)
Inventor
金振珠
全相映
洪性佶
崔愍偶
全贤秀
金宰垠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Chem Ltd
Original Assignee
LG Chem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LG Chem Ltd filed Critical LG Chem Ltd
Publication of CN114364678A publication Critical patent/CN114364678A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/633Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising polycyclic condensed aromatic hydrocarbons as substituents on the nitrogen atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/18Carrier blocking layers
    • H10K50/181Electron blocking layers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Indole Compounds (AREA)

Abstract

The present specification provides a compound represented by chemical formula 1 and an organic light emitting device including the same.

Description

Compound and organic light emitting device including the same
Technical Field
The present application claims priority of korean patent application No. 10-2019-0145641, which was filed on 14.11.2019 to the korean patent office, the entire contents of which are incorporated herein.
The present specification relates to a compound and an organic light emitting device including the same.
Background
In general, the organic light emitting phenomenon refers to a phenomenon of converting electric energy into light energy using an organic substance. An organic light emitting device using an organic light emitting phenomenon generally has a structure including an anode and a cathode with an organic layer therebetween. Here, in order to improve the efficiency and stability of the organic light emitting device, the organic layer is often formed of a multilayer structure composed of different materials, and may be formed of, for example, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, or the like. With the structure of such an organic light emitting device, if a voltage is applied between the two electrodes, holes are injected from the anode into the organic layer, electrons are injected from the cathode into the organic layer, and when the injected holes and electrons meet, excitons (exiton) are formed, which emit light when they transition to the ground state again.
There is a continuing demand for the development of new materials for organic light emitting devices as described above.
Documents of the prior art
(patent document 1) laid-open patent publication No. 10-2015-0011347
Disclosure of Invention
Technical subject
Provided in the present specification are compounds and organic light emitting devices comprising the same.
Means for solving the problems
One embodiment of the present specification provides a compound represented by the following chemical formula 1.
[ chemical formula 1]
Figure BDA0003523438580000021
In the above-described chemical formula 1,
r is hydrogen, deuterium, a substituted or unsubstituted alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic group, or combines with adjacent groups to form a substituted or unsubstituted ring,
r1 to R16, which are the same as or different from each other, are each independently hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylamine group, or a substituted or unsubstituted heterocyclic group, or combine with each other to form a substituted or unsubstituted ring, at least one of R1 to R11 and R14 to R16 is represented by the following chemical formula 2,
[ chemical formula 2]
Figure BDA0003523438580000022
In the above-described chemical formula 2,
l1 and L2, which are the same or different from each other, are each independently a direct bond, a substituted or unsubstituted arylene group, or a substituted or unsubstituted 2-valent heterocyclic group,
ar1 and Ar2, which are the same or different from each other, are each independently a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocyclic group,
at least one of Ar1 and Ar2 is a substituted or unsubstituted fluorenyl group,
when any one of R1 to R8 is represented by chemical formula 2, R4 or R5 combines with R to form a substituted or unsubstituted ring,
indicates the position of binding to R1 to R11 and R14 to R16.
In addition, an embodiment of the present specification provides an organic light emitting device including: the organic light emitting device includes a first electrode, a second electrode, and 1 or more organic layers disposed between the first electrode and the second electrode, wherein 1 or more of the organic layers include a compound represented by the chemical formula 1.
Effects of the invention
The compound described in this specification can be used as a material for an organic layer of an organic light-emitting device. The compound according to at least one embodiment may achieve an improvement in efficiency, a lower driving voltage, and/or an improvement in lifetime characteristics in an organic light emitting device. In particular, the compound described in the present specification can be used as a material for hole injection, hole transport, hole injection and hole transport, electron blocking, light emission, hole blocking, electron transport, or electron injection. In addition, compared with the existing organic light emitting device, the organic light emitting device has the effects of low driving voltage, high efficiency or long service life.
Drawings
Fig. 1 illustrates an example of an organic light emitting device in which a substrate 1, an anode 2, a light emitting layer 7, and a cathode 9 are sequentially stacked.
Fig. 2 illustrates an example of an organic light emitting device in which a substrate 1, an anode 2, a hole injection layer 3, a hole transport layer 4, an electron blocking layer 5, a light emitting layer 7, an electron injection and transport layer 8, and a cathode 9 are sequentially stacked.
Fig. 3 illustrates an example of an organic light emitting device in which a substrate 1, an anode 2, a hole injection layer 3, a hole transport layer 4, a light emitting layer 7, an electron injection and transport layer 8, and a cathode 9 are sequentially stacked.
Fig. 4 illustrates an example of an organic light emitting device in which a substrate 1, an anode 2, a hole injection layer 3, a hole transport layer 4, a light emission auxiliary layer 6, a light emitting layer 7, an electron injection and transport layer 8, and a cathode 9 are sequentially stacked.
Description of the symbols
1: substrate
2: anode
3: hole injection layer
4: hole transport layer
5: electron blocking layer
6: luminescence auxiliary layer
7: luminescent layer
8: electron injection and transport layer
9: cathode electrode
Detailed Description
The present specification will be described in more detail below.
In the present specification, when a part of "includes" a certain component is referred to, unless otherwise stated, it means that the other component may be further included without excluding the other component.
In the present specification, when it is stated that a certain member is "on" another member, it includes not only a case where the certain member is in contact with the other member but also a case where the other member exists between the two members.
In the present specification, examples of the substituent are described below, but the substituent is not limited thereto.
In the context of the present specification,
Figure BDA0003523438580000041
indicates a site to which another substituent or a binding moiety binds.
The term "substituted" means that a hydrogen atom bonded to a carbon atom of a compound is substituted with another substituent, and the substituted position is not limited as long as the hydrogen atom can be substituted, that is, the substituent can be substituted, and when 2 or more substituents are substituted, 2 or more substituents may be the same as or different from each other.
In the present specification, the term "substituted or unsubstituted" means substituted with 1 or 2 or more substituents selected from deuterium, a halogen group, a nitrile group, a nitro group, a hydroxyl group, an amino group, a silyl group, a boron group, an alkoxy group, an aryloxy group, an alkyl group, a cycloalkyl group, an aryl group, and a heterocyclic group, or a substituent in which 2 or more substituents among the above-exemplified substituents are linked, or does not have any substituent. For example, "a substituent in which 2 or more substituents are linked" may be a biphenyl group. That is, the biphenyl group may be an aryl group or may be interpreted as a substituent in which 2 phenyl groups are linked.
In the present specification, the term "substituted or unsubstituted" means substituted with 1 or 2 or more substituents selected from deuterium, a halogen group, a nitrile group, an alkyl group, a cycloalkyl group, an aryl group, and a heterocyclic group, or a substituent in which 2 or more substituents among the above-exemplified substituents are linked, or does not have any substituent.
Examples of the above-mentioned substituent are described below, but the substituent is not limited thereto.
In the present specification, as examples of the halogen group, there are fluorine (-F), chlorine (-Cl), bromine (-Br) or iodine (-I).
In the present specification, the silyl group may be represented by-SiYaYbYcThe above-mentioned chemical formula is Ya、YbAnd YcMay each be hydrogen, substituted or unsubstituted alkyl, or substituted or unsubstituted aryl. Specific examples of the silyl group include, but are not limited to, a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, and a phenylsilyl group.
In this specification, the boron group may be represented BY-BYdYeThe above-mentioned chemical formula is YdAnd YeMay each be hydrogen, substituted or unsubstituted alkyl, or substituted or unsubstituted aryl. The boron group includes, but is not limited to, a trimethylboron group, a triethylboron group, a t-butyldimethylboron group, a triphenylboron group, and a phenylboron group.
In the present specification, the oxygen of the ether group may be preferably substituted with a linear, branched or cyclic alkyl group having 1 to 30 carbon atoms or an aryl group having 6 to 60 carbon atoms. In particular, the above-mentioned ether groups are, for example, -REther 0-O-REther 1Thus represented, REther 0And REther 1The alkyl group having 1 to 30 carbon atoms, the cycloalkyl group having 3 to 60 carbon atoms, or the aryl group having 6 to 60 carbon atoms may be used, but the present invention is not limited thereto.
In the present specification, the alkyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 60. According to one embodiment, the alkyl group has 1 to 30 carbon atoms. According to another embodiment, the alkyl group has 1 to 20 carbon atoms. According to another embodiment, the alkyl group has 1 to 10 carbon atoms. Specific examples of the alkyl group include, but are not limited to, methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, pentyl, n-pentyl, hexyl, n-hexyl, heptyl, n-heptyl, octyl, and n-octyl.
In the present specification, haloalkyl means an alkyl group substituted with a halogen group.
In the present specification, the above description of the alkyl group can be applied to the arylalkyl group except for the aryl group.
In the present specification, the alkoxy group may be linear, branched or cyclic. The number of carbon atoms of the alkoxy group is not particularly limited, but the number of carbon atoms is preferably 1 to 20. Specifically, it may be methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, n-hexoxy, 3-dimethylbutoxy, 2-ethylbutoxy, n-octoxy, n-nonoxy, n-decoxy, etc., but is not limited thereto.
The alkyl group, the alkoxy group and other substituents containing an alkyl moiety described in the present specification are all included in a linear or branched form.
In the present specification, haloalkoxy means alkoxy substituted with a halogen group.
In the present specification, the alkenyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. According to one embodiment, the number of carbon atoms of the alkenyl group is 2 to 20. According to another embodiment, the number of carbon atoms of the alkenyl group is 2 to 10. According to another embodiment, the number of carbon atoms of the above alkenyl group is 2 to 6. Specific examples thereof include, but are not limited to, vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-methyl-1-butenyl, 1, 3-butadienyl, allyl, 1-phenylethen-1-yl, 2-diphenylethen-1-yl, 2-phenyl-2- (naphthalen-1-yl) ethen-1-yl, 2-bis (biphenyl-1-yl) ethen-1-yl, stilbenyl, and styryl.
In the present specification, the cycloalkyl group is not particularly limited, but is preferably a cycloalkyl group having 3 to 60 carbon atoms, and according to one embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 30. According to another embodiment, the cycloalkyl group has 3 to 20 carbon atoms. According to another embodiment, the number of carbon atoms of the above cycloalkyl group is 3 to 6. Specifically, there are, but not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl.
In the present specification, the amino group is-NH2The above-mentioned amino group may be substituted with the above-mentioned alkyl group, aryl group, heterocyclic group, alkenyl group, cycloalkyl group, a combination thereof, or the like. The number of carbon atoms of the substituted amine group is not particularly limited, but is preferably 1 to 30. According to one embodiment, the number of carbon atoms of the amine group is 1 to 20. According to one embodiment, the number of carbon atoms of the amine group is 1 to 10. Specific examples of the substituted amino group include, but are not limited to, a methylamino group, a dimethylamino group, an ethylamino group, a diethylamino group, a phenylamino group, a 9, 9-dimethylfluorenylphenylamino group, a pyridylphenylamino group, a diphenylamino group, a phenylpyridinylamino group, a naphthylamino group, a biphenylamino group, an anthrylamino group, a dibenzofuranylphenylamino group, a 9-methylanthrylamino group, a diphenylamino group, a phenylnaphthylamino group, a ditolylamino group, a phenyltolylamino group, and a diphenylamino group.
In the present specification, the aryl group is not particularly limited, but is preferably an aryl group having 6 to 60 carbon atoms, and may be a monocyclic aryl group or a polycyclic aryl group. According to one embodiment, the aryl group has 6 to 30 carbon atoms. According to one embodiment, the aryl group has 6 to 20 carbon atoms. The aryl group may be a monocyclic aryl group such as a phenyl group, a biphenyl group, a terphenyl group, a quaterphenyl group, but is not limited thereto. As the above polycyclic aromatic group, may be mentionedNaphthyl, anthryl, phenanthryl, pyrenyl, perylenyl, triphenyl, perylene,
Figure BDA0003523438580000061
Examples of the group include, but are not limited to, a fluorenyl group, a triphenylene group, and the like.
In the present specification, the fluorenyl group may be substituted, and 2 substituents may be combined with each other to form a spiro structure. In the case where the above-mentioned fluorenyl group is substituted, it may be
Figure BDA0003523438580000071
(9, 9-dimethylfluorenyl),
Figure BDA0003523438580000072
(9-methyl-9-phenylfluorenyl),
Figure BDA0003523438580000073
(9, 9-diphenylfluorenyl),
Figure BDA0003523438580000074
Figure BDA0003523438580000075
And the like, but is not limited thereto.
In the present specification, the aryl group in the aryloxy group can be applied to the description about the aryl group described above.
In the present specification, the heterocyclic group includes N, O, P, S, Si and 1 or more of Se as heteroatoms, and the number of carbon atoms is not particularly limited, but is preferably 2 to 60. According to one embodiment, the number of carbon atoms of the heterocyclic group is 2 to 30. Examples of the heterocyclic group include pyridyl, pyrrolyl, pyrimidinyl, pyridazinyl, furyl, thienyl, benzofuryl, benzothienyl, dibenzofuryl, carbazolyl, dibenzothienyl, imidazolyl, pyrazolyl, and the like,
Figure BDA0003523438580000076
Azolyl radical, iso
Figure BDA0003523438580000077
Oxazolyl, thiazolyl, isothiazolyl, triazolyl,
Figure BDA0003523438580000078
Oxadiazolyl, thiadiazolyl, dithiazolyl, tetrazolyl, pyranyl, thiapyranyl, pyrazinyl, pyranyl, thiadiazolyl, and thiadiazolyl,
Figure BDA0003523438580000079
oxazinyl, thiazinyl, di
Figure BDA00035234385800000710
Alkenyl, triazinyl, tetrazinyl, quinolinyl, isoquinolinyl, quinolonoyl, quinazolinyl, quinoxalinyl, naphthyridinyl, acridinyl, xanthenyl, phenanthridinyl, naphthyridinyl, triazindyl, indolyl, indolinyl, indolizinyl, phthalazinyl, pyridopyrimidinyl, pyridopyrazinyl, pyrazinyl, benzothiazolyl, benzoxazolyl, quinazolinyl, quinoxalinyl, naphthyridinyl, xanthenyl, phenanthridinyl, naphthyridinyl, pyridopyrimidinyl, pyridopyrazinyl, pyrazinyl, pyridopyrazinyl, naphthyridinyl, quinoxalinyl, xanthinyl, phenanthridinyl, quinoxalinyl, and a
Figure BDA00035234385800000711
Azolyl, benzimidazolyl, phenazinyl, imidazopyridinyl, pheno
Figure BDA00035234385800000712
Examples of the substituent include, but are not limited to, an oxazinyl group, a phenanthridinyl group, a phenanthrolinyl group, a phenothiazinyl group, an imidazopyridinyl group, an imidazophenanthridinyl group, a benzimidazoloquinazolinyl group, and a benzimidazolophenanthridinyl group.
In the present specification, sulfonyl is-SO2R0Sulfinyl is-SOR0Sulfamoyl is-SO2NR0The sulfonate group is-SO3R0R is as defined above0Each independently is a linear or branched alkyl group having 1 to 60 carbon atoms, an aryl group having 6 to 40 carbon atoms, or a heteroaryl group having 2 to 40 carbon atoms. In one embodiment, R is0Each independently is a linear or branched alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 18 carbon atoms, or a heteroaryl group having 2 to 20 carbon atoms.
In the present specification, the heteroaryl group may be aromatic, and the above description about the heterocyclic group may be applied.
In the present specification, in a substituted or unsubstituted ring formed by bonding adjacent groups to each other, "ring" means a hydrocarbon ring or a heterocyclic ring.
The hydrocarbon ring may be aromatic, aliphatic, or a fused ring of aromatic and aliphatic, and may be selected from the cycloalkyl groups and the aryl groups described above in addition to the 2-valent group described above.
In the present specification, the meaning that adjacent groups are bonded to each other to form a ring is that adjacent groups are bonded to each other to form a substituted or unsubstituted aliphatic hydrocarbon ring, a substituted or unsubstituted aromatic hydrocarbon ring, a substituted or unsubstituted aliphatic heterocyclic ring, a substituted or unsubstituted aromatic heterocyclic ring, or a fused ring thereof. The above-mentioned hydrocarbon ring means a ring composed of only carbon and hydrogen atoms. The heterocyclic ring includes at least 1 ring selected from N, O, P, S, Si and Se. In the present specification, the above-mentioned aliphatic hydrocarbon ring, aromatic hydrocarbon ring, aliphatic heterocyclic ring and aromatic heterocyclic ring may be monocyclic or polycyclic.
In the present specification, an aliphatic hydrocarbon ring means a ring which is not an aromatic ring and is composed of only carbon and hydrogen atoms. Examples of the aliphatic hydrocarbon ring include cyclopropane, cyclobutane, cyclobutene, cyclopentane, cyclopentene, cyclohexane, cyclohexene, 1, 4-cyclohexadiene, cycloheptane, cycloheptene, cyclooctane, cyclooctene, and the like, but are not limited thereto.
In the present specification, the aromatic hydrocarbon ring refers to an aromatic ring composed of only carbon and hydrogen atoms. Examples of the aromatic hydrocarbon ring include benzene, naphthalene, anthracene, phenanthrene, perylene, fluoranthene, triphenylene, phenalene, pyrene, tetracene, perylene, and the like,
Figure BDA0003523438580000081
Pentacene, fluorene, indene, acenaphthylene, benzofluorene, spirofluorene, etc., but is not limited thereto. In the present specification, the aromatic hydrocarbon ring may be interpreted as having the same meaning as the aryl group.
In the present specification, the aliphatic heterocyclic ring means 1 out of 1 containing hetero atomsThe above aliphatic ring. Examples of the aliphatic heterocyclic ring include ethylene oxide (oxirane), tetrahydrofuran, and 1, 4-bis
Figure BDA0003523438580000082
Alkanes (1,4-dioxane), pyrrolidine, piperidine, morpholine (morpholine), oxepane
Figure BDA0003523438580000083
Figure BDA0003523438580000084
Azacyclooctane
Figure BDA0003523438580000085
Thiocyclooctane
Figure BDA0003523438580000086
And the like, but is not limited thereto.
In the present specification, an aromatic heterocyclic ring means an aromatic ring containing 1 or more heteroatoms. Examples of the aromatic heterocyclic ring include pyridine, pyrrole, pyrimidine, pyridazine, furan, thiophene, imidazole, pyrazole, and the like,
Figure BDA0003523438580000087
Oxazole, iso
Figure BDA0003523438580000088
Oxazole, thiazole, isothiazole, triazole, and the like,
Figure BDA0003523438580000089
Oxadiazoles, thiadiazoles, dithiazoles, tetrazoles, pyrans, thiopyrans, pyridazines,
Figure BDA00035234385800000810
Oxazine, thiazine, II
Figure BDA00035234385800000811
Alkene, triazine, tetrazine, isoquinoline, quinoline, quinone, quinazoline, quinoxaline, naphthyridine, acridine, phenanthridine, naphthyridine, triazaHeteroandene, indole, indolizine, benzothiazole, benzo
Figure BDA00035234385800000812
Oxazole, benzimidazole, benzothiophene, benzofuran, dibenzothiophene, dibenzofuran, carbazole, benzocarbazole, dibenzocarbazole, phenazine, imidazopyridine, thiophene
Figure BDA00035234385800000813
Oxazines, indolocarbazoles, indenocarbazoles, and the like, but are not limited thereto.
Preferred embodiments of the present invention will be described in detail below. However, the embodiment of the present invention may be modified into various forms, and the scope of the present invention is not limited to the embodiment described below.
The present specification provides a compound represented by the following chemical formula 1. When the compound represented by the following chemical formula 1 is used for an organic layer of an organic light emitting device, the efficiency of the organic light emitting device is improved, and the compound has a low driving voltage and excellent life characteristics.
Chemical formula 1 according to the present invention is characterized in that amine groups including a fluorene group are combined in a spiroacridine fluorene structure through an o-phenylene group (chemical formula 2). In the case of the phenylene group having an amine group connected in an ortho position as in chemical formula 1, the HOMO level is relatively shallow and holes (holes) are easily transferred from a layer adjacent to an anode side, as compared with the compound having the phenylene group connected in a para (para) or meta (meta) position, and thus the voltage reduction effect is exhibited at the time of device driving. Furthermore, triplet energy is highest when having phenylene groups attached at ortho-positions, and thus electrons passing through the light emitting layer can be effectively blocked.
When the amine group contains a fluorene group, the mobility of holes is higher than when a general aryl group, for example, a biphenyl group, is connected, and the HOMO level adjustment is facilitated according to the bonding position of the fluorene group, and therefore, it is effective in matching the energy difference with the adjacent layer.
The following describes the chemical formula 1 in detail.
[ chemical formula 1]
Figure BDA0003523438580000091
In the above-described chemical formula 1,
r is hydrogen, deuterium, a substituted or unsubstituted alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic group, or combines with adjacent groups to form a substituted or unsubstituted ring,
r1 to R16, which are the same as or different from each other, are each independently hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylamine group, or a substituted or unsubstituted heterocyclic group, or combine with each other to form a substituted or unsubstituted ring, at least one of R1 to R11 and R14 to R16 is represented by the following chemical formula 2,
[ chemical formula 2]
Figure BDA0003523438580000101
In the above-described chemical formula 2,
l1 and L2, which are the same or different from each other, are each independently a direct bond, a substituted or unsubstituted arylene group, or a substituted or unsubstituted 2-valent heterocyclic group,
ar1 and Ar2, which are the same or different from each other, are each independently a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocyclic group,
at least one of Ar1 and Ar2 is a substituted or unsubstituted fluorenyl group,
when any one of R1 to R8 is represented by chemical formula 2, R4 or R5 combines with R to form a substituted or unsubstituted ring,
indicates the position of binding to R1 to R11 and R14 to R16.
According to an embodiment of the present specification, R is hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or a substituted or unsubstituted heterocyclic group having 2 to 30 carbon atoms, or is combined with an adjacent group to form a substituted or unsubstituted ring having 2 to 30 carbon atoms.
According to an embodiment of the present specification, R is hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or a substituted or unsubstituted heterocyclic group having 2 to 20 carbon atoms, or is combined with an adjacent group to form a substituted or unsubstituted ring having 2 to 20 carbon atoms.
According to an embodiment of the present specification, R is a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, or a substituted or unsubstituted heterocyclic group having 2 to 20 carbon atoms, or is combined with an adjacent group to form a substituted or unsubstituted ring having 2 to 20 carbon atoms.
According to an embodiment of the present specification, R is a substituted or unsubstituted aryl group having 6 to 20 carbon atoms; or a substituted or unsubstituted heterocyclic group having 2 to 20 carbon atoms, or is directly bonded to each other with R4 or R5; or a ring containing O, S, N, P, C ═ O, C or Si is formed. In this case, the ring is substituted or unsubstituted with 1 or more substituents selected from the group consisting of hydrogen, alkyl groups, alkoxy groups, alkenyl groups, aryl groups, arylamine groups, heterocyclic groups, nitrile groups, amide groups, and ester groups, and the substituents may form a condensed ring and a spiro structure.
According to an embodiment of the present specification, R is a substituted or unsubstituted phenyl group, or forms a ring in combination with an adjacent group.
According to an embodiment of the present specification, R is a substituted or unsubstituted phenyl group, or combines with each other with adjacent groups to form a carbazole ring.
According to an embodiment of the present description, R is phenyl, or is combined with R4 or R5 to form a carbazole ring.
According to an embodiment of the present specification, R is a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, or is directly bonded to R4 or R5 to form a ring having 2 to 30 carbon atoms.
According to an embodiment of the present specification, R is a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, and the above R is directly bonded to R4 or R5 to form a ring having 2 to 30 carbon atoms.
According to an embodiment of the present description, R is a substituted or unsubstituted phenyl and forms a direct bond with R4 or R5.
According to an embodiment of the present description, R is phenyl and forms a direct bond with R4 or R5.
According to an embodiment of the present description, R is phenyl.
According to an embodiment of the present specification, R1 to R16 are the same as or different from each other, and each independently represents hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted arylamine group having 6 to 30 carbon atoms, or a substituted or unsubstituted heterocyclic group having 2 to 30 carbon atoms, or are combined with adjacent groups to form a substituted or unsubstituted ring having 2 to 30 carbon atoms.
According to an embodiment of the present specification, R1 to R16 are the same as or different from each other, and each independently represents hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 20 carbon atoms, a substituted or unsubstituted arylamine group having 6 to 20 carbon atoms, or a substituted or unsubstituted heterocyclic group having 2 to 20 carbon atoms, or are combined with adjacent groups to form a substituted or unsubstituted ring having 2 to 20 carbon atoms.
According to one embodiment of the present specification, at least one of R1 to R11 and R14 to R16 is represented by the above chemical formula 2, and the others are the same as or different from each other, each independently hydrogen or deuterium, or combine with adjacent groups to each other to form a substituted or unsubstituted ring.
According to one embodiment of the present specification, at least one of R1 to R11 and R14 to R16 is represented by the above chemical formula 2, and the others are the same as or different from each other, and each independently hydrogen or deuterium, or combine with adjacent groups to form a substituted or unsubstituted ring having 2 to 30 carbon atoms.
According to an embodiment of the present specification, at least one of R1 to R11 and R14 to R16 is represented by the above chemical formula 2, and the others are the same or different from each other and each independently hydrogen or deuterium, and R4 and R5 may be directly bonded to R to form a substituted or unsubstituted carbazole ring.
According to an embodiment of the present specification, at least one of R1 to R11 and R14 to R16 is represented by the above chemical formula 2, and the others are the same or different from each other and are each independently hydrogen or deuterium, and R4 and R5 may be directly bonded to R to form a carbazole ring.
According to an embodiment of the present specification, at least one of R1 to R11 and R14 to R16 is represented by the above chemical formula 2, and the remainder is hydrogen, and R4 and R5 may be directly bonded to R to form a carbazole ring.
According to an embodiment of the present specification, at least one of R1 to R3, R5 to R11, and R14 to R16 is represented by the above chemical formula 2, and the remainder is hydrogen, and R4 may combine with R to form a carbazole ring.
According to one embodiment of the present disclosure, R4 and R combine with each other to form a carbazole ring.
According to one embodiment of the present disclosure, R5 and R combine with each other to form a carbazole ring.
According to an embodiment of the present specification, at least one of R1 to R11 and R14 to R16 is represented by the above chemical formula 2, and the rest not represented by the above chemical formula 2 is hydrogen.
According to an embodiment of the present description, R12 and R13 are hydrogen or deuterium.
According to an embodiment of the present description, R12 and R13 are hydrogen.
According to an embodiment of the present specification, at least one of R1 to R11 and R14 to R16 is represented by the following chemical formula 2.
[ chemical formula 2]
Figure BDA0003523438580000131
In the above-described chemical formula 2,
l1 and L2, which are the same or different from each other, are each independently a direct bond, a substituted or unsubstituted arylene group, or a substituted or unsubstituted 2-valent heterocyclic group,
ar1 and Ar2, which are the same or different from each other, are each independently a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocyclic group,
at least one of Ar1 and Ar2 is a substituted or unsubstituted fluorenyl group,
when any one of R1 to R8 is represented by chemical formula 2, R4 or R5 combines with R to form a substituted or unsubstituted ring,
indicates the position of binding to R1 to R11 and R14 to R16.
According to an embodiment of the present specification, L1 and L2, which are the same or different from each other, are each independently a direct bond, a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted heterocyclic group having 2 valences and having 2 to 30 carbon atoms.
According to an embodiment of the present specification, L1 and L2, which are the same or different from each other, are each independently a direct bond, a substituted or unsubstituted arylene group having 6 to 20 carbon atoms, or a substituted or unsubstituted heterocyclic group having 2 valences and having 2 to 20 carbon atoms.
According to an embodiment of the present specification, L1 and L2, which are the same or different from each other, are each independently a direct bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms.
According to an embodiment of the present specification, L1 and L2, which are the same or different from each other, are each independently a direct bond, or a substituted or unsubstituted arylene group having 6 to 20 carbon atoms.
According to an embodiment of the present description, L1 and L2, equal to or different from each other, are each independently a direct bond or an arylene group.
According to an embodiment of the present specification, L1 and L2, which are the same or different from each other, are each independently a direct bond, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted biphenylene group.
According to an embodiment of the present description, L1 and L2, equal to or different from each other, are each independently a direct bond, phenylene or biphenylene.
According to an embodiment of the present description, L1 and L2, equal to or different from each other, are each independently a direct bond or a phenylene group.
According to an embodiment of the present description, L1 and L2, equal to or different from each other, are each independently a direct bond, an ortho-phenylene, a meta-phenylene, or a para-phenylene.
According to an embodiment of the present disclosure, L1 and L2 are the same or different from each other, and are each independently a direct bond.
According to an embodiment of the present description, L1 and L2, equal to or different from each other, are each independently phenylene.
According to an embodiment of the present specification, L1 and L2 are the same as or different from each other, and each is independently a direct bond, or represented by any one of the following structural formulae.
Figure BDA0003523438580000141
In the above structural formulae, the dotted line represents a binding site.
According to one embodiment of the present description, L1 is a direct bond or phenylene.
According to one embodiment of the present description, L1 is a direct bond or p-phenylene.
According to one embodiment of the present description, L2 is a direct bond or phenylene.
According to one embodiment of the present description, L2 is a direct bond or p-phenylene.
According to an embodiment of the present specification, Ar1 and Ar2, which are the same or different from each other, are each independently a substituted or unsubstituted aryl group having 6 to 30 carbon atoms or a substituted or unsubstituted heterocyclic group having 2 to 30 carbon atoms.
According to an embodiment of the present specification, Ar1 and Ar2, which are the same or different from each other, are each independently a substituted or unsubstituted aryl group having 6 to 20 carbon atoms or a substituted or unsubstituted heterocyclic group having 2 to 20 carbon atoms.
According to an embodiment of the present specification, Ar1 and Ar2, which are the same or different from each other, are each independently a substituted or unsubstituted aryl group having 6 to 20 carbon atoms.
According to an embodiment of the present specification, Ar1 and Ar2, equal to or different from each other, are each independently an aryl group substituted or unsubstituted with an alkyl group or an aryl group.
According to an embodiment of the present specification, Ar1 and Ar2, which are the same as or different from each other, are each independently an aryl group of 6 to 30 carbon atoms substituted or unsubstituted with an alkyl group of 1 to 20 carbon atoms or an aryl group of 6 to 30 carbon atoms.
According to an embodiment of the present specification, Ar1 and Ar2, which are the same or different from each other, are each independently a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, or a substituted or unsubstituted fluorenyl group.
According to an embodiment of the present specification, Ar1 and Ar2, which are the same or different from each other, are each independently a phenyl group substituted or unsubstituted with an alkyl group or an aryl group, a biphenyl group substituted or unsubstituted with an alkyl group or an aryl group, a terphenyl group substituted or unsubstituted with an alkyl group or an aryl group, or a fluorenyl group substituted or unsubstituted with an alkyl group or an aryl group.
According to an embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently is a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, or a fluorenyl group substituted or unsubstituted with an alkyl group.
According to an embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each independently is a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, or a fluorenyl group substituted or unsubstituted with a methyl group.
According to an embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each is independently a phenyl group, a biphenyl group, or a dimethylfluorenyl group.
According to an embodiment of the present specification, Ar1 and Ar2 are the same as or different from each other, and each is independently represented by any one of the following structural formulae.
Figure BDA0003523438580000151
In the above structural formulae, the dotted line represents a binding site.
According to an embodiment of the present description, Ar1 is a substituted or unsubstituted fluorenyl group.
According to an embodiment of the present description, Ar1 is a fluorenyl group substituted or unsubstituted with an alkyl or aryl group.
According to an embodiment of the present specification, Ar1 is a fluorenyl group substituted or unsubstituted with an alkyl group.
According to an embodiment of the present description, Ar1 is dimethylfluorenyl.
According to one embodiment of the present description, Ar2 is a substituted or unsubstituted aryl group.
According to one embodiment of the present specification, Ar2 is a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
According to one embodiment of the present specification, Ar2 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, or a substituted or unsubstituted fluorenyl group.
According to an embodiment of the present specification, Ar2 is a phenyl group, a biphenyl group, or a fluorenyl group substituted or unsubstituted with an alkyl group or an aryl group.
According to an embodiment of the present specification, Ar2 is a phenyl group, a biphenyl group, or a fluorenyl group substituted or unsubstituted with an alkyl group.
According to an embodiment of the present description, Ar2 is phenyl, biphenyl, or dimethylfluorenyl.
According to an embodiment of the present description, at least one of Ar1 and Ar2 is a substituted or unsubstituted fluorenyl group.
According to an embodiment of the present description, at least one of Ar1 and Ar2 is a fluorenyl group substituted or unsubstituted with an alkyl group or an aryl group.
According to an embodiment of the present specification, at least one of Ar1 and Ar2 is a fluorenyl group substituted or unsubstituted with an alkyl group having 1 to 20 carbon atoms or an aryl group having 6 to 30 carbon atoms.
According to an embodiment of the present specification, at least one of Ar1 and Ar2 is a fluorenyl group substituted or unsubstituted with an alkyl group having 1 to 20 carbon atoms.
According to an embodiment of the present description, at least one of Ar1 and Ar2 is a dimethylfluorenyl group.
According to an embodiment of the present disclosure, Ar1 is a substituted or unsubstituted fluorenyl group and Ar2 is a substituted or unsubstituted aryl group.
According to one embodiment of the present specification, Ar1 is a substituted or unsubstituted fluorenyl group, and Ar2 is a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
According to an embodiment of the present specification, Ar1 is a substituted or unsubstituted fluorenyl group, and Ar2 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, or a substituted or unsubstituted fluorenyl group.
According to an embodiment of the present specification, Ar1 is a fluorenyl group substituted or unsubstituted with an alkyl group or an aryl group, and Ar2 is a phenyl group, a biphenyl group, or a fluorenyl group substituted or unsubstituted with an alkyl group or an aryl group.
According to an embodiment of the present specification, Ar1 is a fluorenyl group substituted or unsubstituted with an alkyl group, and Ar2 is a phenyl group, a biphenyl group, or a fluorenyl group substituted or unsubstituted with an alkyl group.
According to one embodiment of the present disclosure, Ar1 is a dimethylfluorenyl group, and Ar2 is a phenyl group, a biphenyl group, or a dimethylfluorenyl group.
According to one embodiment of the present disclosure, Ar1 is a dimethylfluorenyl group and Ar2 is a phenyl group.
According to one embodiment of the present disclosure, Ar1 is a dimethylfluorenyl group and Ar2 is a biphenyl group.
According to an embodiment of the present description, Ar1 and Ar2 are dimethylfluorenyl.
According to an embodiment of the present specification, when any one of R1 to R8 is represented by chemical formula 2, R4 or R5 is directly bonded to R to form a substituted or unsubstituted ring.
According to an embodiment of the present specification, when any one of R1 to R8 is represented by chemical formula 2, R4 or R5 is directly bonded to R to form a carbazole ring.
According to an embodiment of the present specification, when any one of R1 to R3 and R5 to R8 is represented by chemical formula 2, R4 and R are directly bonded to form a carbazole ring.
According to an embodiment of the present specification, when any one of R1 to R4 and R6 to R8 is represented by chemical formula 2, R5 and R are directly bonded to form a carbazole ring.
According to an embodiment of the present disclosure, the chemical formula 2 is represented by the following chemical formula 2-1.
[ chemical formula 2-1]
Figure BDA0003523438580000171
In the above chemical formula 2-1, L1, L2 and Ar2 are defined as in chemical formula 2,
ar3 and Ar4, which are the same or different from each other, are each independently a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aryl group.
According to an embodiment of the present specification, Ar3 and Ar4, which are the same or different from each other, are each independently a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms or a substituted or unsubstituted aryl group having 6 to 60 carbon atoms.
According to an embodiment of the present specification, Ar3 and Ar4, which are the same as or different from each other, are each independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
According to an embodiment of the present specification, Ar3 and Ar4, which are the same or different from each other, are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms.
According to an embodiment of the present specification, Ar3 and Ar4, equal to or different from each other, are each independently a substituted or unsubstituted alkyl group. According to an embodiment of the present specification, Ar3 and Ar4, equal to or different from each other, are each independently a substituted or unsubstituted phenyl group, or a substituted or unsubstituted methyl group.
According to an embodiment of the present description, Ar3 and Ar4 are methyl.
According to an embodiment of the present specification, the chemical formula 2 is represented by any one of the following chemical formulas 2-1-1 to 2-1-4.
[ chemical formula 2-1-1]
Figure BDA0003523438580000181
[ chemical formula 2-1-2]
Figure BDA0003523438580000182
[ chemical formulas 2-1-3]
Figure BDA0003523438580000183
[ chemical formulas 2-1-4]
Figure BDA0003523438580000191
In the above chemical formulas 2-1-1 to 2-1-4, L1, L2, and Ar2 to Ar4 are defined as in chemical formula 2.
According to an embodiment of the present specification, the chemical formula 1 is represented by the following chemical formula 1-1.
[ chemical formula 1-1]
Figure BDA0003523438580000192
In the above chemical formula 1-1,
g1 to G3 and G5 to G16, which are the same or different from each other, are each independently hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylamine group, or a substituted or unsubstituted heterocyclic group, or combine with adjacent groups to form a substituted or unsubstituted ring.
At least one of G1 to G3, G5 to G11, and G14 to G16 is represented by the above chemical formula 2.
In one embodiment of the present specification, at least one of G1 to G3, G5 to G11, and G14 to G16 is represented by the above chemical formula 2, and the others are the same as or different from each other, and each is independently hydrogen or deuterium.
In one embodiment of the present specification, at least one of G1 to G3, G5 to G11, and G14 to G16 is represented by the above chemical formula 2, and the rest is hydrogen.
In one embodiment of the present specification, any one of G1 to G3, G5 to G11, and G14 to G16 is represented by the above chemical formula 2, and the remainder is hydrogen.
In one embodiment of the present specification, at least one of G1 to G3 and G5 to G8 is represented by the above chemical formula 2.
In one embodiment of the present specification, at least one of G1 to G3 is represented by the above chemical formula 2.
In one embodiment of the present specification, at least one of G5 to G8 is represented by the above chemical formula 2.
In one embodiment of the present specification, G5 is represented by chemical formula 2.
In one embodiment of the present specification, G6 is represented by chemical formula 2.
In one embodiment of the present specification, G7 is represented by chemical formula 2.
In one embodiment of the present specification, G8 is represented by chemical formula 2.
In one embodiment of the present specification, at least one of G9 to G11 and G14 to G16 is represented by the above chemical formula 2.
In one embodiment of the present specification, G14 is represented by chemical formula 2.
In one embodiment of the present specification, G15 is represented by chemical formula 2.
In one embodiment of the present specification, G16 is represented by chemical formula 2.
In one embodiment of the present disclosure, the definitions of G1-G16 may be applied to the definitions of R1-R16.
According to an embodiment of the present disclosure, the chemical formula 1 is represented by the following chemical formula 1-2.
[ chemical formulas 1-2]
Figure BDA0003523438580000211
In the above chemical formula 1-2,
y1 to Y16 are the same as or different from each other, and each independently hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylamine group, or a substituted or unsubstituted heterocyclic group, or combine with adjacent groups to form a substituted or unsubstituted ring, and at least one of Y9 to Y11 and Y14 to Y16 is represented by the above chemical formula 2.
In one embodiment of the present specification, Y1 to Y8, Y12 and Y13 are the same or different from each other, and each is independently hydrogen or deuterium.
In one embodiment of the present specification, Y1 to Y8, Y12 and Y13 are hydrogen.
In one embodiment of the present specification, at least one of Y9 to Y11 and Y14 to Y16 is represented by the above chemical formula 2, and the others are the same as or different from each other, and each is independently hydrogen or deuterium.
In one embodiment of the present specification, at least one of Y9 to Y11 and Y14 to Y16 is represented by the above chemical formula 2, and the rest is hydrogen.
In one embodiment of the present specification, any one of Y9 to Y11 and Y14 to Y16 is represented by the above chemical formula 2, and the remainder is hydrogen.
In one embodiment of the present specification, Y9 is represented by chemical formula 2.
In one embodiment of the present specification, Y10 is represented by chemical formula 2.
In one embodiment of the present specification, Y11 is represented by chemical formula 2.
In one embodiment of the present specification, Y14 is represented by chemical formula 2.
In one embodiment of the present specification, Y15 is represented by chemical formula 2.
In one embodiment of the present specification, Y16 is represented by chemical formula 2.
In one embodiment of the present disclosure, the definitions of Y1 to Y16 may be applied to the definitions of R1 to R16.
According to an embodiment of the present specification, the chemical formula 1 is represented by any one of the following chemical formulas 3-1 to 3-7.
[ chemical formula 3-1]
Figure BDA0003523438580000221
[ chemical formula 3-2]
Figure BDA0003523438580000222
[ chemical formulas 3-3]
Figure BDA0003523438580000231
[ chemical formulas 3-4]
Figure BDA0003523438580000232
[ chemical formulas 3-5]
Figure BDA0003523438580000241
[ chemical formulas 3-6]
Figure BDA0003523438580000242
[ chemical formulas 3 to 7]
Figure BDA0003523438580000251
In the above chemical formulas 3-1 to 3-7, R1 to R3 and R5 to R16 are defined as in chemical formula 1, and L1, L2, Ar1 and Ar2 are defined as in chemical formula 2.
According to an embodiment of the present specification, the chemical formula 1 is represented by any one of the following chemical formulas 4-1 to 4-3.
[ chemical formula 4-1]
Figure BDA0003523438580000252
[ chemical formula 4-2]
Figure BDA0003523438580000261
[ chemical formulas 4-3]
Figure BDA0003523438580000262
In the above chemical formulas 4-1 to 4-3, R1 to R16 are defined as in chemical formula 1, and L1, L2, Ar1 and Ar2 are defined as in chemical formula 2.
According to an embodiment of the present disclosure, the chemical formula 1 may be represented by any one of the following structural formulae.
Figure BDA0003523438580000271
Figure BDA0003523438580000281
Figure BDA0003523438580000291
Figure BDA0003523438580000301
Figure BDA0003523438580000311
Figure BDA0003523438580000321
Figure BDA0003523438580000331
Figure BDA0003523438580000341
Figure BDA0003523438580000351
The compound represented by chemical formula 1 according to one embodiment of the present specification can be produced into a core structure as in the production example described later. The substituents may be combined by a method known in the art, and the kind, position or number of the substituents may be changed according to a technique known in the art.
In the present invention, compounds having various energy band gaps can be synthesized by introducing various substituents into the core structure of the compound represented by the above chemical formula 1. In the present invention, the HOMO and LUMO levels of the compound can also be adjusted by introducing various substituents into the core structure of the above-described structure.
In addition, the present specification provides an organic light emitting device comprising the above-mentioned compound.
In one embodiment of the present specification, there is provided an organic light emitting device including: the organic light-emitting device includes a first electrode, a second electrode, and 1 or more organic layers provided between the first electrode and the second electrode, wherein 1 or more of the organic layers contain the compound.
In the present specification, when it is stated that a certain member is "on" another member, it includes not only a case where the certain member is in contact with the other member but also a case where the other member exists between the two members.
In the present specification, when a part of "includes" a certain component is referred to, unless otherwise stated, it means that the other component may be further included without excluding the other component.
The organic layer of the organic light-emitting device in the present specification may have a single-layer structure, or may have a multilayer structure in which 2 or more organic layers are stacked. For example, as a representative example of the organic light emitting device of the present specification, the organic light emitting device may have a structure including a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron injection layer, an electron blocking layer, a hole blocking layer, and the like as an organic layer. The structure of the organic light emitting device is not limited thereto and a smaller number of organic layers may be included.
In one embodiment of the present disclosure, the organic layer includes a light emitting layer, and the light emitting layer may include a compound represented by the chemical formula 1.
In one embodiment of the present specification, the light-emitting layer may further contain a phosphorescent substance or a delayed fluorescence compound. The delayed fluorescence compound is a light-emitting organic compound having an energy gap (Δ Est) between the lowest triplet state T1 and the first excited singlet state S1 of 0.2eV or less.
When the energy gap (Δ Est) between the first excited singlet state S1 and the lowest triplet state T1 of the delayed fluorescent compound satisfies the above range, the rate and speed at which excitons generated in the triplet state migrate to the singlet state through reverse intersystem crossing (RISC) are increased, thereby reducing the time during which the excitons stay in the triplet state, and thus there is an advantage in that the efficiency and lifetime of the organic light emitting device are increased.
In one embodiment of the present specification, the organic layer includes a hole injection layer, a hole transport layer, a hole injection and transport layer, an electron blocking layer, or a light emission auxiliary layer, and the hole injection layer, the hole transport layer, the hole injection and transport layer, the electron blocking layer, or the light emission auxiliary layer of the organic layer includes the compound represented by the chemical formula 1.
In one embodiment of the present specification, the organic layer includes a hole injection layer, a hole transport layer, or a hole injection and transport layer, and the hole injection layer, the hole transport layer, or the hole injection and transport layer includes the compound represented by chemical formula 1.
In one embodiment of the present disclosure, the organic layer includes a hole injection layer, and the hole injection layer includes a compound represented by the chemical formula 1.
In one embodiment of the present disclosure, the organic layer includes a hole transport layer, and the hole transport layer includes a compound represented by the chemical formula 1.
In one embodiment of the present disclosure, the organic layer includes an electron blocking layer, and the electron blocking layer includes a compound represented by the chemical formula 1.
In one embodiment of the present disclosure, the organic layer includes a light-emitting auxiliary layer including the compound represented by chemical formula 1.
In the organic light emitting device of the present specification, the organic layer includes a hole transport layer and a hole injection layer, and the hole transport layer and the hole injection layer may each include a compound represented by the above chemical formula 1.
In one embodiment of the present specification, the organic layer is a hole injection layer, and the hole injection layer includes a compound represented by the chemical formula 1.
In one embodiment of the present specification, the organic layer is a hole transport layer, and the hole transport layer includes a compound represented by the chemical formula 1.
In one embodiment of the present disclosure, the organic layer is an electron blocking layer, and the electron blocking layer includes a compound represented by the chemical formula 1.
In one embodiment of the present disclosure, the organic layer is a light-emitting auxiliary layer, and the light-emitting auxiliary layer includes a compound represented by the chemical formula 1.
In one embodiment of the present specification, the organic layer including the compound represented by the above chemical formula 1 may have a thickness of
Figure BDA0003523438580000371
To
Figure BDA0003523438580000372
Or
Figure BDA0003523438580000373
To
Figure BDA0003523438580000374
Or
Figure BDA0003523438580000375
To
Figure BDA0003523438580000376
In another embodiment, the organic layer including the compound represented by the above chemical formula 1 may have a thickness of
Figure BDA0003523438580000377
To
Figure BDA0003523438580000378
Or
Figure BDA0003523438580000379
To
Figure BDA00035234385800003710
Or
Figure BDA00035234385800003711
To
Figure BDA00035234385800003712
In another embodiment, the organic layer may further include a metal or a metal compound in addition to the compound represented by the chemical formula 1.
In one embodiment of the present specification, the organic light-emitting device further includes 1 or 2 or more layers selected from a hole injection layer, a hole transport layer, a light-emitting layer, an electron transport layer, an electron injection layer, a hole blocking layer, and an electron blocking layer.
In one embodiment of the present specification, the organic light emitting device includes a first electrode, a second electrode, a light emitting layer disposed between the first electrode and the second electrode, and 2 or more organic layers disposed between the light emitting layer and the first electrode or between the light emitting layer and the second electrode, and at least one of the 2 or more organic layers includes the compound represented by chemical formula 1.
In one embodiment of the present specification, the organic light emitting device includes a first electrode, a second electrode, a light emitting layer disposed between the first electrode and the second electrode, and 2 or more organic layers disposed between the light emitting layer and the first electrode or between the light emitting layer and the second electrode, and at least 2 of the 2 or more organic layers include the compound represented by chemical formula 1.
In one embodiment of the present specification, the 2 or more organic layers may be 2 or more selected from a light-emitting layer, a hole-transporting layer, a hole-injecting layer, a layer that simultaneously performs hole transport and hole injection, and an electron-blocking layer.
In one embodiment of the present specification, the 2 or more organic layers may be 2 or more selected from a light-emitting layer, an electron transport layer, an electron injection layer, a layer that simultaneously performs electron transport and electron injection, an electron adjustment layer, and a hole blocking layer.
In one embodiment of the present disclosure, the organic layer includes 1 or more hole injection layers and 1 or more hole transport layers, and at least one of the 1 or more hole injection layers and the 1 or more hole transport layers includes the compound represented by chemical formula 1. Specifically, in one embodiment of the present specification, the compound represented by the above chemical formula 1 may be included in 1 layer of 1 or more hole injection layers and 1 or more hole transport layers, and may be included in each of 1 or more hole injection layers and 1 or more hole transport layers.
In another embodiment, the organic layer including the compound represented by the above chemical formula 1 may include an additional organic compound. For example, the organic layer including the compound represented by the above chemical formula 1 may further include 4- [ [2,3-bis [ cyano- (4-cyano-2,3,5,6-tetrafluorophenyl) methylene ] cyclopropyl ] -cyanomethyl ] -2,3,5,6-tetrafluorobenzonitrile (4- [ [2,3-bis [ cyano- (4-cyano-2,3,5,6-tetrafluorophenyl) methylidene ] cyclopropyrene ] -cyclomethenyl ] -2,3,5, 6-tetrafluorobenzonitrile). According to an example, the compound represented by the above chemical formula 1 and the above organic compound may be included in a weight ratio of 100:0.1 to 100:30, for example, 100:1 to 100: 10.
In one embodiment of the present disclosure, the organic layer includes 2 or more hole transport layers, and at least one of the 2 or more hole transport layers includes the compound represented by chemical formula 1. Specifically, in one embodiment of the present specification, the compound represented by the above chemical formula 1 may be contained in 1 layer of the 2 or more hole transport layers, and may be contained in each of the 2 or more hole transport layers.
In addition, in an embodiment of the present specification, when the compound is included in each of the 2 or more hole transport layers, materials other than the compound represented by the above chemical formula 1 may be the same or different from each other.
In one embodiment of the present specification, the organic layer may include a hole injection layer or a hole transport layer including a compound including an arylamine group, a carbazole group, or a benzocarbazole group, in addition to the organic layer including the compound represented by chemical formula 1.
In one embodiment of the present disclosure, the first electrode is an anode, and the second electrode is a cathode.
In another embodiment, the first electrode is a cathode and the second electrode is an anode.
In one embodiment of the present specification, the organic light-emitting device may have a structure (normal type) in which an anode, 1 or more organic layers, and a cathode are sequentially stacked on a substrate.
In one embodiment of the present disclosure, the organic light emitting device may have a reverse structure (inverted type) in which a cathode, 1 or more organic layers, and an anode are sequentially stacked on a substrate.
For example, fig. 1 to 4 illustrate the structure of an organic light emitting device according to an embodiment of the present specification. The organic light emitting device is illustrated in fig. 1 to 4, but is not limited thereto.
Fig. 1 illustrates a structure of an organic light emitting device in which a substrate 1, an anode 2, a light emitting layer 7, and a cathode 9 are sequentially stacked. In the structure as described above, the above-described compound may be contained in the above-described light-emitting layer 7.
Fig. 2 illustrates a structure of an organic light emitting device in which a substrate 1, an anode 2, a hole injection layer 3, a hole transport layer 4, an electron blocking layer 5, a light emitting layer 7, an electron injection and transport layer 8, and a cathode 9 are sequentially stacked. In the structure as described above, the above compound may be contained in 1 or more of the above hole injection layer 3, hole transport layer 4, electron blocking layer 5, light emitting layer 7, and electron injection and transport layer 8.
Fig. 3 illustrates a structure of an organic light emitting device in which a substrate 1, an anode 2, a hole injection layer 3, a hole transport layer 4, a light emitting layer 7, an electron injection and transport layer 8, and a cathode 9 are sequentially stacked. In the structure as described above, the above compound may be contained in 1 or more of the above hole injection layer 3, hole transport layer 4, light emitting layer 7, and electron injection and transport layer 8.
Fig. 4 illustrates a structure of an organic light emitting device in which a substrate 1, an anode 2, a hole injection layer 3, a hole transport layer 4, a light emission auxiliary layer 6, a light emitting layer 7, an electron injection and transport layer 8, and a cathode 9 are sequentially stacked. In the structure as described above, the above compound may be contained in 1 or more of the above hole injection layer 3, hole transport layer 4, light emission auxiliary layer 6, light emitting layer 7, and electron injection and transport layer 8.
The organic light emitting device of the present specification may be manufactured by materials and methods known in the art, except that 1 or more of the organic layers include the above compound, i.e., the compound represented by the above chemical formula 1.
In the case where the organic light emitting device includes a plurality of organic layers, the organic layers may be formed of the same substance or different substances.
For example, the organic light emitting device of the present specification can be manufactured by sequentially laminating a first electrode, an organic layer, and a second electrode on a substrate. In this case, the following production can be performed: the organic el display device is manufactured by depositing a metal, a metal oxide having conductivity, or an alloy thereof on a substrate by a PVD (physical Vapor Deposition) method such as a sputtering method or an electron beam evaporation method (e-beam evaporation) method to form an anode, forming an organic layer including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer on the anode, and then depositing a substance that can be used as a cathode on the organic layer. In addition to this method, an organic light-emitting device may be manufactured by depositing a cathode material, an organic material layer, and an anode material on a substrate in this order.
In addition, the compound represented by the above chemical formula 1 may be formed into an organic layer not only by a vacuum evaporation method but also by a solution coating method in the manufacture of an organic light emitting device. Here, the solution coating method refers to spin coating, dip coating, blade coating, inkjet printing, screen printing, spraying, roll coating, and the like, but is not limited thereto.
In addition to these methods, a cathode material, an organic layer, and an anode material may be sequentially deposited on a substrate to manufacture an organic light-emitting device. However, the production method is not limited thereto.
The first electrode material is usually used for making a voidThe hole can be smoothly injected into the organic layer, and is preferably a substance having a large work function. For example, there are metals such as vanadium, chromium, copper, zinc, gold, etc., or alloys thereof; metal oxides such as zinc oxide, Indium Tin Oxide (ITO), and Indium Zinc Oxide (IZO); ZnO-Al or SnO2A combination of a metal such as Sb and an oxide; poly (3-methylthiophene), poly [3,4- (ethylene-1, 2-dioxy) thiophene]Conductive polymers such as (PEDOT), polypyrrole, and polyaniline, but the present invention is not limited thereto.
The second electrode material is preferably a material having a small work function in order to easily inject electrons into the organic layer. For example, there are metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; LiF/Al or LiO2And a multilayer structure material such as Al, but not limited thereto.
The light emitting layer may comprise additional host and dopant materials. The host material may be an aromatic fused ring derivative or a heterocyclic ring-containing compound. Specifically, the aromatic condensed ring derivative includes an anthracene derivative, a pyrene derivative, a naphthalene derivative, a pentacene derivative, a phenanthrene compound, a fluoranthene compound, and the like, and the heterocyclic ring-containing compound includes a dibenzofuran derivative and a ladder-type furan compound
Figure BDA0003523438580000411
Figure BDA0003523438580000412
Pyrimidine derivatives, etc., but are not limited thereto.
As the dopant material, there are aromatic amine derivatives, styryl amine compounds, boron complexes, fluoranthene compounds, metal complexes, and the like. Specifically, the aromatic amine derivative is an aromatic fused ring derivative having a substituted or unsubstituted arylamine group, and includes pyrene, anthracene, perylene, and the like having an arylamine group,
Figure BDA0003523438580000413
Diindenopyrene, and the like. Further, the styrylamine compound is a compound substituted with at least a substituted or unsubstituted arylamine1 arylethenyl compound, substituted or unsubstituted with 1 or 2 or more substituents selected from aryl, silyl, alkyl, cycloalkyl and arylamine groups. Specific examples thereof include, but are not limited to, styrylamine, styryldiamine, styryltrimethylamine, and styryltretramine. The metal complex includes, but is not limited to, iridium complexes and platinum complexes.
In the present specification, when an additional light-emitting layer is provided, the light-emitting substance of the light-emitting layer is a substance which can receive holes and electrons from the hole-transporting layer and the electron-transporting layer, respectively, and combine them to emit light in the visible light region, and is preferably a substance having high quantum efficiency with respect to fluorescence or phosphorescence. For example, there are 8-hydroxy-quinoline aluminum complexes (Alq 3); a carbazole-based compound; dimeric styryl (dimerized styryl) compounds; BAlq; 10-hydroxybenzoquinoline-metal compounds; benzo (b) is
Figure BDA0003523438580000414
Azole, benzothiazole and benzimidazole-based compounds; poly (p-phenylene vinylene) (PPV) polymers; spiro (spiroo) compounds; a polyfluorene; and rubrene, but the present invention is not limited thereto.
The hole injection layer is a layer for injecting holes from the electrode. The hole injection substance is preferably as follows: has the ability to transport holes, has the effect of injecting holes from the first electrode, and has an excellent hole injection effect for the light-emitting layer or the light-emitting material. In addition, a substance excellent in the ability to prevent excitons generated in the light-emitting layer from migrating to the electron injection layer or the electron injection material is preferable. Further, a substance having excellent film-forming ability is preferable. Further, it is preferable that the HOMO (highest occupied molecular orbital) of the hole injecting substance is between the work function of the first electrode substance and the HOMO of the surrounding organic layer. Specific examples of the hole injecting substance include metalloporphyrin (porphyrin), oligothiophene, and arylamine-based organic substances; a carbazole-based organic substance; a nitrile-based organic compound; hexanenitrile hexaazatriphenylene series organic matter; quinacridone (quinacridone) -based organic compounds; perylene (perylene) -based organic compounds; anthraquinone, polyaniline, and polythiophene-based conductive polymers, or a mixture of 2 or more of the above-mentioned examples, but the present invention is not limited thereto. In addition, the compound represented by the above chemical formula 1 may be used.
The hole transport layer is a layer that receives holes from the hole injection layer and transports the holes to the light emitting layer. The hole-transporting substance is a substance capable of receiving holes from the first electrode or the hole-injecting layer and transferring the holes to the light-emitting layer, and is preferably a substance having a high mobility to holes. Specific examples thereof include, but are not limited to, arylamine-based organic substances, carbazole-based organic substances, conductive polymers, and block copolymers in which a conjugated portion and a non-conjugated portion are present simultaneously. In addition, the compound represented by the above chemical formula 1 may be used.
The electron transport layer receives electrons from the electron injection layer and transports the electrons to the light emitting layer. The electron transport material is a material capable of receiving electrons from the second electrode and transferring the electrons to the light-emitting layer, and is preferably a material having a high mobility to electrons. Specific examples thereof include, but are not limited to, Al complexes of 8-hydroxyquinoline, complexes containing Alq3, organic radical compounds, hydroxyflavone-metal complexes, triazine derivatives, LiQ, and the like. The electron transport layer may be used with any desired first electrode material as used in the art. Suitable first electrode substances are, in particular, the usual substances having a low work function and accompanied by an aluminum or silver layer. In particular cesium, barium, calcium, ytterbium, samarium, etc., in each case accompanied by an aluminum or silver layer.
The electron injection layer is a layer for injecting electrons from the electrode. The electron-injecting substance is preferably as follows: a substance having an excellent ability to transport electrons, having an effect of injecting electrons from the second electrode, and having an excellent electron injection effect for the light-emitting layer or the light-emitting material. Further, it is preferable that the material prevents excitons generated in the light-emitting layer from migrating to the hole-injecting layer and has excellent thin-film-forming ability. Specifically, there are fluorenone, anthraquinone dimethane, diphenoquinone, thiopyran dioxide, and the like,
Figure BDA0003523438580000421
Azole,
Figure BDA0003523438580000422
Oxadiazole, triazole, triazine, imidazole, perylene tetracarboxylic acid, fluorenylidene methane, anthrone, and the like and their derivatives, metal complex compounds, and nitrogen-containing five-membered ring derivatives, and mixtures of 2 or more of the above examples, but not limited thereto.
Examples of the metal complex include lithium 8-quinolinolato, zinc bis (8-quinolinolato), copper bis (8-quinolinolato), manganese bis (8-quinolinolato), aluminum tris (2-methyl-8-quinolinolato), and gallium tris (8-quinolinolato), bis (10-hydroxybenzo [ h ] quinoline) beryllium, bis (10-hydroxybenzo [ h ] quinoline) zinc, bis (2-methyl-8-quinoline) gallium chloride, bis (2-methyl-8-quinoline) (o-cresol) gallium, bis (2-methyl-8-quinoline) (1-naphthol) aluminum, bis (2-methyl-8-quinoline) (2-naphthol) gallium, and the like, but are not limited thereto.
The electron blocking layer is a layer that prevents holes injected from the hole injection layer from entering the electron injection layer through the light emitting layer, so that the lifetime and efficiency of the device can be improved. Any known material can be used without limitation, and the light-emitting layer and the hole-injecting layer or the light-emitting layer and the layer which performs hole injection and hole transport simultaneously can be formed therebetween.
The hole blocking layer is a layer that prevents holes from reaching the second electrode, and can be formed under the same conditions as those of the hole injection layer. Specifically, there are
Figure BDA0003523438580000431
An oxadiazole derivative or a triazole derivative, a phenanthroline derivative, an aluminum complex (aluminum complex), pyridine, pyrimidine, or triazine derivative, and the like, but is not limited thereto.
The electron control layer is a layer for controlling the migration of electrons to the light-emitting layer, and materials known in the art can be used.
The organic light emitting device according to the present specification may be a top emission type, a bottom emission type, or a bi-directional emission type, depending on the material used.
In one embodiment of the present specification, the compound represented by the above chemical formula 1 may be included in an organic solar cell or an organic transistor, in addition to the organic light emitting device.
The compound according to the present specification can also function in an organic light-emitting device typified by an organic phosphorescent device, an organic solar cell, an organic photoreceptor, an organic transistor, or the like, according to a principle similar to that applied to the organic light-emitting device. For example, the organic solar cell may have a structure including a cathode, an anode, and a photoactive layer disposed between the cathode and the anode, and the photoactive layer may include the compound.
Modes for carrying out the invention
Hereinafter, in order to specifically explain the present specification, the details will be explained by referring to examples, comparative examples, and the like. However, the examples and comparative examples according to the present specification may be modified into various forms, and the scope of the present specification is not to be construed as being limited to the examples and comparative examples described in detail below. The examples and comparative examples of the present specification are provided to more fully describe the present specification to those skilled in the art.
< Synthesis example >
[ Synthesis example 1] Synthesis of Compound 1
Figure BDA0003523438580000432
10.0g (20.64mmol) of the above 12'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] (12'-bromospiro [ fluoro-9, 8' -indolo [3,2,1-de ] acridine ]), 8.37g (20.64mmol) of (2- ((9,9-dimethyl-9H-fluoren-2-yl) (phenyl) amino) phenyl) boronic acid (2- ((9, 9-dimethyl-9H-fluoro-2-yl) (phenyl) amino) phenyl) boronic acid) and 2 mol% of tetrakis (triphenylphosphine) palladium were added to 80ml of tetrahydrofuran, and 8.56g (61.92mmol) of potassium carbonate (potassium carbonate) was dissolved in 40ml of water and stirred. After stirring at 80 ℃ for 12 hours, the reaction was terminated, cooled to normal temperature, and the water and organic layers were separated. Only the organic layer was taken, anhydrous magnesium sulfate was added thereto, stirring was performed, and after filtration through a silica gel pad (silica pad), the solution was concentrated under reduced pressure. Then, column purification was performed, whereby 11.37g of compound 1 was obtained (yield 72%).
MS:[M+H]+=765
[ Synthesis example 2] Synthesis of Compound 2
Figure BDA0003523438580000441
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 12'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 9.94g (20.64mmol) of (2- ([1,1'-biphenyl ] -4-yl (9,9-dimethyl-9H-fluoren-3-yl) amino) phenyl) boronic acid (2- ([1,1' -biphenyl ] -4-yl (9, 9-dimethyl-9H-fluoro-3-yl) amino) phenyl) boronic acid), and purifying was carried out to obtain 12.15g of the compound 2 (yield 70%).
MS:[M+H]+=842
[ Synthesis example 3] Synthesis of Compound 3
Figure BDA0003523438580000451
Using 10.0g (20.64mmol) of the above-mentioned 11'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] (11'-bromospiro [ fluorone-9, 8' -indolo [3,2,1-de ] acridine ]) and 9.94g (20.64mmol) of (2- ([1,1'-biphenyl ] -4-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid ((2- ([1,1' -biphenyl ] -4-yl (9, 9-dimethyl-9H-fluoron-2-yl) amino) phenyl) boronic acid), the reaction was carried out in the same manner as in the synthesis of the above compound 1, and purification was carried out, whereby 13.02g of compound 3 was obtained (yield 75%).
MS:[M+H]+=842
[ Synthesis example 4] Synthesis of Compound 4
Figure BDA0003523438580000452
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 11'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 9.94g (20.64mmol) of (2- ([1,1'-biphenyl ] -3-yl (9,9-dimethyl-9H-fluoren-4-yl) amino) phenyl) boronic acid ((2- ([1,1' -biphenyl ] -3-yl (9, 9-dimethyl-9H-fluoro-4-yl) amin o) phenyl) boronic acid), and purification was carried out to obtain 13.02g of the compound 4 (yield 75%).
MS:[M+H]+=842
[ Synthesis example 5] Synthesis of Compound 5
Figure BDA0003523438580000461
Using 10.0g (20.64mmol) of the above-mentioned 10'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] (10'-bromospiro [ fluorone-9, 8' -indolo [3,2,1-de ] acridine ]) and 9.94g (20.64mmol) of (2- ([1,1'-biphenyl ] -2-yl (9,9-dimethyl-9H-fluoren-1-yl) amino) phenyl) boronic acid ((2- ([1,1' -biphenyl ] -2-yl (9, 9-dimethyl-9H-fluoron-1-yl) amino) phenyl) boronic acid), the reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1, and purification was carried out, whereby 11.80g of compound 5 was obtained (yield 68%).
MS:[M+H]+=842
[ Synthesis example 6] Synthesis of Compound 6
Figure BDA0003523438580000462
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 10' -bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 9.94g (20.64mmol) of (2- ([1,1' -biphenyl ] -4-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purification was carried out, thereby obtaining 12.85g of a compound 6 (yield 74%).
MS:[M+H]+=842
[ Synthesis example 7] Synthesis of Compound 7
Figure BDA0003523438580000471
The reaction was carried out and the purification was carried out in the same manner as the synthesis of the above-mentioned compound 1, except for using 10.0g (20.64mmol) of the above-mentioned 9' -bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] (9' -bromospiro [ fluoro [3,2,1-de ] acridine ] (9' -fluorospiro [ fluorone-9, 8' -indolo [3,2,1-de ] acridine ] (9' -bromospiro [3,2,1-de ] acridine ] (9' -dimethyl-9H-fluoren-2-yl) phenyl) (phenyl) amino) phenyl) boronic acid ((2- ((4- (9, 9-dimethyl-9H-fluoro-2-yl) phenyl) (phenyl) amino) phenyl) boronic acid) (20.64mmol), thereby obtaining 11.46g of the compound 7 (yield 66%).
MS:[M+H]+=842
[ Synthesis example 8] Synthesis of Compound 8
Figure BDA0003523438580000472
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1, and purification was carried out, except for using 10.0g (20.64mmol) of the above-mentioned 9'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 8.37g (20.64mmol) of (2- ((9,9-dimethyl-9H-fluoren-4-yl) (phenyl) amino) phenyl) boronic acid ((2- ((9, 9-dimethyl-9H-fluoro-4-yl) (phenyl) amino) phenyl) boronic acid), whereby 11.20g of the compound 8 was obtained (yield 71%).
MS:[M+H]+=765
[ Synthesis example 9] Synthesis of Compound 9
Figure BDA0003523438580000481
Using 10.0g (20.64mmol) of the above-mentioned 1-bromospiro [ fluorene-9,8'-indolo [3,2,1-de ] acridine ] (1-bromospiro [ fluoroene-9, 8' -indolo [3,2,1-de ] acridine ]) and 9.94g (20.64mmol) of (2- ([1,1'-biphenyl ] -2-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid ((2- ([1,1' -biphenyl ] -2-yl (9, 9-dimethyl-9H-fluoroen-2-yl) amino) phenyl) boronic acid), the reaction was carried out in the same manner as in the synthesis of the above compound 1, and purification was carried out, whereby 9.37g of compound 9 was obtained (yield 59%).
MS:[M+H]+=842
Synthesis example 10 Synthesis of Compound 10
Figure BDA0003523438580000482
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1, except for using 10.0g (20.64mmol) of the above-mentioned 1-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 9.94g (20.64mmol) of (2- ((4- (9,9-dimethyl-9H-fluoren-2-yl) phenyl) (phenyl) amino) phenyl) boronic acid, and purification was carried out, thereby obtaining 9.15g of compound 10 (yield 58%).
MS:[M+H]+=765
[ Synthesis example 11] Synthesis of Compound 11
Figure BDA0003523438580000491
The reaction was carried out in the same manner as the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 2-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] (2-bromospiro [ fluoroene-9, 8' -indolo [3,2,1-de ] acridine ]) and 9.94g (20.64mmol) of (2- ([1,1' -biphenyl ] -4-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purification was carried out to obtain 12.50g of the compound 11 (yield 72%).
MS:[M+H]+=842
Synthesis example 12 Synthesis of Compound 12
Figure BDA0003523438580000492
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1, except for using 10.0g (20.64mmol) of the above-mentioned 2-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 9.94g (20.64mmol) of (2- ((4- (9,9-dimethyl-9H-fluoren-2-yl) phenyl) (phenyl) amino) phenyl) boronic acid, and purifying, thereby obtaining 12.67g of the compound 12 (yield 73%).
MS:[M+H]+=842
[ Synthesis example 13] Synthesis of Compound 13
Figure BDA0003523438580000501
Using 10.0g (20.64mmol) of the above-mentioned 3-bromospiro [ fluorene-9,8'-indolo [3,2,1-de ] acridine ] (3-bromospiro [ fluoroene-9, 8' -indolo [3,2,1-de ] acridine ]) and 9.94g (20.64mmol) of (2- ([1,1'-biphenyl ] -3-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid ((2- ([1,1' -biphenyl ] -3-yl (9, 9-dimethyl-9H-fluoroen-2-yl) amino) phenyl) boronic acid), the reaction was carried out in the same manner as in the synthesis of the above compound 1, and purification was carried out, whereby 12.15g of compound 13 was obtained (yield 70%).
MS:[M+H]+=842
Synthesis example 14 Synthesis of Compound 14
Figure BDA0003523438580000502
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 3-bromospiro [ fluorene-9,8'-indolo [3,2,1-de ] acridine ] and 9.94g (20.64mmol) of (2- ([1,1' -biphenyl ] -4-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purification was carried out, thereby obtaining 12.32g of the compound 14 (yield 70%).
MS:[M+H]+=842
[ Synthesis example 15] Synthesis of Compound 15
Figure BDA0003523438580000511
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 and purification was carried out by using 10.0g (20.56mmol) of the above-mentioned 1'-bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] (1'-bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ]) and 8.33g (20.56mmol) of (2- ((9,9-dimethyl-9H-fluoren-3-yl) (phenyl) amino) phenyl) boronic acid ((2- ((9, 9-dimethyl-9H-fluoro-3-yl) (phenyl) amino) phenyl) boronic acid), thereby obtaining 8.67g of a compound 15 (yield 55%).
MS:[M+H]+=767
Synthesis example 16 Synthesis of Compound 16
Figure BDA0003523438580000512
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1, except for using 10.0g (20.56mmol) of the above-mentioned 1' -bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] and 9.90g (20.56mmol) of (2- ([1,1' -biphenyl ] -4-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purification was carried out, thereby obtaining 9.01g of the compound 16 (yield 51%).
MS:[M+H]+=844
[ Synthesis example 17] Synthesis of Compound 17
Figure BDA0003523438580000521
The reaction was carried out in the same manner as the synthesis of the above-mentioned compound 1 except for using 10.0g (20.56mmol) of the above-mentioned 2' -bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] (2' -bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ]) and 9.90g (20.56mmol) of (2- ([1,1' -biphenyl ] -4-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purifying, thereby obtaining 12.30g of the compound 17 (yield 71%).
MS:[M+H]+=844
[ Synthesis example 18] Synthesis of Compound 18
Figure BDA0003523438580000522
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.56mmol) of the above-mentioned 2'-bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] and 9.90g (20.56mmol) of (2- ((9,9-dimethyl-9H-fluoren-2-yl) (phenyl) amino) phenyl) boronic acid, and purifying, thereby obtaining 11.67g of a compound 18 (yield 74%).
MS:[M+H]+=767
[ Synthesis example 19] Synthesis of Compound 19
Figure BDA0003523438580000531
The reaction was carried out in the same manner as the synthesis of the above-mentioned compound 1 except for using 10.0g (20.56mmol) of the above-mentioned 3' -bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] (3' -bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ]) and 9.90g (20.56mmol) of (2- ([1,1' -biphenyl ] -4-yl (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purifying, thereby obtaining 12.13g of the compound 19 (yield 70%).
MS:[M+H]+=844
[ Synthesis example 20] Synthesis of Compound 20
Figure BDA0003523438580000532
The reaction and purification were carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.56mmol) of the above-mentioned 3'-bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] and 9.90g (20.56mmol) of (2- ((4- (9,9-dimethyl-9H-fluoren-1-yl) phenyl) (phenyl) amino) phenyl) boronic acid ((2- ((4- (9, 9-dimethyl-9H-fluoro-1-yl) phenyl) (phenyl) amino) phenyl) boronic acid), thereby obtaining 11.78g of the compound 20 (yield 68%).
MS:[M+H]+=844
Synthesis example 21 Synthesis of Compound 21
Figure BDA0003523438580000541
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 12'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- (bis (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid ((2- (bis (9, 9-dimethyl-9H-fluoro-2-yl) amino) phenyl) boronic acid), and purifying it, thereby obtaining 10.73g of the compound 21 (yield 59%).
MS:[M+H]+=882
[ Synthesis example 22] Synthesis of Compound 22
Figure BDA0003523438580000542
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 11'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- (bis (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purification was carried out to obtain 11.05g of the compound 22 (yield 61%).
MS:[M+H]+=882
[ Synthesis example 23] Synthesis of Compound 23
Figure BDA0003523438580000543
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 10'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- (bis (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purification was carried out to obtain 11.42g of a compound 23 (yield 63%).
MS:[M+H]+=882
Synthesis example 24 Synthesis of Compound 24
Figure BDA0003523438580000551
9.42g of Compound 24 (yield 52%) was obtained by conducting a reaction and purification in the same manner as in the synthesis of Compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 9'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- (bis (9,9-dimethyl-9H-fluoren-3-yl) amino) phenyl) boronic acid ((2- (bis (9, 9-dimethyl-9H-fluoro-3-yl) amino) phenyl) boronic acid).
MS:[M+H]+=882
Synthesis example 25 Synthesis of Compound 25
Figure BDA0003523438580000552
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 10'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- ((9,9-dimethyl-9H-fluoren-2-yl) (9,9-dimethyl-9H-fluoren-3-yl) amino) phenyl) boronic acid ((2- ((9, 9-dimethyl-9H-fluoro-2-yl) (9, 9-dimethyl-9H-fluoro-3-yl) amino) phenyl) boronic acid), and purifying, thereby obtaining 11.23g of the compound 25 (yield 62%).
MS:[M+H]+=882
[ Synthesis example 26] Synthesis of Compound 26
Figure BDA0003523438580000561
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 9'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- ((9,9-dimethyl-9H-fluoren-3-yl) (9,9-dimethyl-9H-fluoren-4-yl) amino) phenyl) boronic acid ((2- ((9, 9-dimethyl-9H-fluoro-3-yl) (9, 9-dimethyl-9H-fluoro-4-yl) amino) phenyl) boronic acid), and purifying, thereby obtaining 9.06g of the compound 26 (yield 50%).
MS:[M+H]+=882
[ Synthesis example 27] Synthesis of Compound 27
Figure BDA0003523438580000562
A reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1, except for using 10.0g (20.64mmol) of the above-mentioned 1-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- ((9,9-dimethyl-9H-fluoren-2-yl) (9,9-dimethyl-9H-fluoren-4-yl) amino) phenyl) boronic acid ((2- ((9, 9-dimethyl-9H-fluoro-2-yl) (9, 9-dimethyl-9H-fluoro-4-yl) amino) phenyl) boronic acid), and purifying it, thereby obtaining 10.33g of the compound 27 (yield 57%).
MS:[M+H]+=882
Synthesis example 28 Synthesis of Compound 28
Figure BDA0003523438580000571
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 2-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- (bis (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purification was carried out to obtain 11.23g of the compound 28 (yield 62%).
MS:[M+H]+=882
Synthesis example 29 Synthesis of Compound 29
Figure BDA0003523438580000572
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 3-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 10.76g (20.64mmol) of (2- (bis (9,9-dimethyl-9H-fluoren-3-yl) amino) phenyl) boronic acid, and purification was carried out to obtain 11.60g of a compound 29 (yield 64%).
MS:[M+H]+=882
[ Synthesis example 30] Synthesis of Compound 30
Figure BDA0003523438580000581
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.56mmol) of the above-mentioned 1'-bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] and 10.72g (20.56mmol) of (2- ((9,9-dimethyl-9H-fluoren-1-yl) (9,9-dimethyl-9H-fluoren-3-yl) amino) phenyl) boronic acid ((2- ((9,9-dimethyl-9H-fluoren-1-yl) (9, 9-dimethyl-9H-fluoro-3-yl) amino) phenyl) boronic acid), and purification was carried out to obtain 9.24g of the compound 30 (yield 51%).
MS:[M+H]+=884
[ Synthesis example 31] Synthesis of Compound 31
Figure BDA0003523438580000582
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.56mmol) of the above-mentioned 2'-bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] and 10.72g (20.56mmol) of (2- (bis (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purifying was carried out to obtain 11.99g of the compound 31 (yield 66%).
MS:[M+H]+=884
[ Synthesis example 32] Synthesis of Compound 32
Figure BDA0003523438580000591
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.56mmol) of the above-mentioned 3'-bromo-10-phenyl-10H-spiro [ acridine-9,9' -fluorene ] and 10.72g (20.56mmol) of (2- (bis (9,9-dimethyl-9H-fluoren-2-yl) amino) phenyl) boronic acid, and purifying them, thereby obtaining 11.44g of a compound 32 (yield 63%).
MS:[M+H]+=884
Synthesis example 33 Synthesis of Compound 33
Figure BDA0003523438580000592
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 10'-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 8.37g (20.64mmol) of (2- ((9,9-dimethyl-9H-fluoren-2-yl) (phenyl) amino) phenyl) boronic acid, and purification was carried out to obtain 10.41g of a compound 33 (yield 64%).
MS:[M+H]+=765
[ Synthesis example 34] Synthesis of Compound 34
Figure BDA0003523438580000593
The reaction was carried out in the same manner as in the synthesis of the above-mentioned compound 1 except for using 10.0g (20.64mmol) of the above-mentioned 2-bromospiro [ fluorene-9,8' -indolo [3,2,1-de ] acridine ] and 8.37g (20.64mmol) of (2- ((9,9-dimethyl-9H-fluoren-2-yl) (phenyl) amino) phenyl) boronic acid, and purification was carried out to obtain 11.04g of the compound 34 (yield 70%).
MS:[M+H]+=765
< Experimental example >
< Experimental examples 1-1>
Indium Tin Oxide (ITO) and a process for producing the same
Figure BDA0003523438580000604
Is coated to a thickness ofThe glass substrate of the thin film was washed with ultrasonic waves by putting it in distilled water in which a detergent was dissolved. In this case, the detergent used was a product of fisher (Fischer Co.) and the distilled water used was distilled water obtained by twice filtration using a Filter (Filter) manufactured by Millipore Co. After washing ITO for 30 minutes, ultrasonic washing was performed for 10 minutes by repeating twice with distilled water. After the completion of the distilled water washing, the resultant was ultrasonically washed with a solvent of isopropyl alcohol, acetone, or methanol, dried, and then transported to a plasma cleaning machine. After the substrate was cleaned with oxygen plasma for 5 minutes, the substrate was transported to a vacuum evaporator.
On the ITO transparent electrode thus prepared, compound 1 produced according to synthesis example 1 above and a compound of the following formula HI-a were vacuum-evaporated at a weight ratio of 100:3 to prepare an ITO transparent electrode
Figure BDA0003523438580000605
The thickness of (3) forms a hole injection layer.
Figure BDA0003523438580000601
On the hole injection layer, compound 1 produced according to synthesis example 1 was used as a hole-transporting substance, and
Figure BDA0003523438580000602
the hole transport layer is formed by vacuum evaporation.
Then, on the hole transport layer, the film thickness
Figure BDA0003523438580000603
The electron blocking layer was formed by vacuum evaporation of EB1(TCTA) described below.
Figure BDA0003523438580000611
Then, on the electron blocking layer, the film thickness
Figure BDA0003523438580000612
The light-emitting layer was formed by vacuum evaporation of BH and BD shown below at a weight ratio of 25: 1.
Figure BDA0003523438580000613
On the light-emitting layer, ET1 and LiQ (Lithium Quinolate) were vacuum-deposited at a weight ratio of 1:1 to form a layer
Figure BDA0003523438580000614
The thickness of (a) forms an electron injection and transport layer.
Figure BDA0003523438580000615
On the above electron injection and transport layer, lithium fluoride (LiF) is sequentially added to
Figure BDA0003523438580000616
Thickness of aluminum and
Figure BDA0003523438580000617
the thickness of (3) is evaporated to form a cathode.
In the above process, the evaporation rate of the organic material is maintained at 0.4-0.4
Figure BDA0003523438580000618
Sec, maintenance of lithium fluoride at the cathode
Figure BDA0003523438580000619
Evaporation Rate,/sec, aluminum maintenance
Figure BDA00035234385800006110
A vapor deposition rate of/sec, and a degree of vacuum of 2X 10 was maintained during vapor deposition-7~5×10-6And supporting to thereby fabricate an organic light emitting device.
< Experimental examples 1-2 to 1-34>
An organic light-emitting device was produced in the same manner as in experimental example 1-1, except that in the above experimental example 1-1, the compounds shown in table 1 below were used instead of compound 1.
Figure BDA0003523438580000621
Figure BDA0003523438580000631
< comparative examples 1-1 and 1-2>
An organic light-emitting device was produced in the same manner as in experimental example 1-1, except that in the above experimental example 1-1, the following comparative example compounds HT1 and HT2 were used, respectively, instead of compound 1.
Figure BDA0003523438580000632
[ Table 1]
Figure BDA0003523438580000641
Figure BDA0003523438580000651
From the results of table 1 described above, experimental examples 1-1 to 1-34 using the compound represented by chemical formula 1 according to the present invention for the hole injection layer and/or the hole transport layer showed results that the driving voltage and the efficiency characteristics were excellent as a whole, as compared to comparative examples 1-1 to and 1-2.
Specifically, experimental examples 1-1 to 1-34 showed the results of a maximum decrease in voltage of about 24% and a maximum increase in efficiency of about 15% as compared to comparative examples 1-1 and 1-2 using a compound not including a fluorenyl group or having a different binding site of chemical formula 2 from that of the present invention.
Accordingly, it can be confirmed that the compound represented by chemical formula 1 according to the present invention shows excellent characteristics in terms of driving voltage and efficiency when used in an organic light emitting device.

Claims (13)

1. A compound represented by the following chemical formula 1:
chemical formula 1
Figure FDA0003523438570000011
In the chemical formula 1, the first and second organic solvents,
r is hydrogen, deuterium, a substituted or unsubstituted alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heterocyclic group, or combines with adjacent groups to form a substituted or unsubstituted ring,
r1 to R16 are the same as or different from each other, and each independently is hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylamine group, or a substituted or unsubstituted heterocyclic group, or combines with adjacent groups to form a substituted or unsubstituted ring, and
at least one of R1 to R11 and R14 to R16 is represented by the following chemical formula 2,
chemical formula 2
Figure FDA0003523438570000012
In the chemical formula 2,
l1 and L2 are the same as or different from each other, and each is independently a direct bond, a substituted or unsubstituted arylene group, or a substituted or unsubstituted 2-valent heterocyclic group,
ar1 and Ar2 are the same as or different from each other and each independently is a substituted or unsubstituted aryl group or a substituted or unsubstituted heterocyclic group,
at least one of Ar1 and Ar2 is a substituted or unsubstituted fluorenyl group,
when any one of R1 to R8 is represented by chemical formula 2, R4 or R5 combines with R to form a substituted or unsubstituted ring, and
indicates the position of binding to R1 to R11 and R14 to R16.
2. The compound according to claim 1, wherein the chemical formula 2 is represented by the following chemical formula 2-1:
chemical formula 2-1
Figure FDA0003523438570000021
In the chemical formula 2-1, L1, L2 and Ar2 are defined as in chemical formula 2, and
ar3 and Ar4 are the same as or different from each other, and each independently is a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aryl group.
3. The compound according to claim 1, wherein the chemical formula 1 is represented by the following chemical formula 1-1:
chemical formula 1-1
Figure FDA0003523438570000031
In the chemical formula 1-1,
g1 to G3 and G5 to G16 are the same as or different from each other, and are each independently hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylamine group, or a substituted or unsubstituted heterocyclic group, or combine with adjacent groups to each other to form a substituted or unsubstituted ring, and
at least one of G1 to G3, G5 to G11, and G14 to G16 is represented by the chemical formula 2.
4. The compound according to claim 1, wherein the chemical formula 1 is represented by the following chemical formula 1-2:
chemical formula 1-2
Figure FDA0003523438570000032
In the chemical formula 1-2,
y1 to Y16 are the same as or different from each other, and each independently hydrogen, deuterium, a nitrile group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted arylamine group, or a substituted or unsubstituted heterocyclic group, or combine with adjacent groups to form a substituted or unsubstituted ring,
at least one of Y9 to Y11 and Y14 to Y16 is represented by the chemical formula 2.
5. The compound according to claim 1, wherein the chemical formula 1 is represented by any one of the following chemical formulae 3-1 to 3-7:
chemical formula 3-1
Figure FDA0003523438570000041
Chemical formula 3-2
Figure FDA0003523438570000042
Chemical formula 3-3
Figure FDA0003523438570000051
Chemical formula 3-4
Figure FDA0003523438570000052
Chemical formula 3-5
Figure FDA0003523438570000061
Chemical formula 3-6
Figure FDA0003523438570000062
Chemical formula 3-7
Figure FDA0003523438570000071
In the chemical formulas 3-1 to 3-7, R1 to R3 and R5 to R16 are defined as in chemical formula 1, and L1, L2, Ar1 and Ar2 are defined as in chemical formula 2.
6. The compound according to claim 1, wherein the chemical formula 1 is represented by any one of the following chemical formulae 4-1 to 4-3:
chemical formula 4-1
Figure FDA0003523438570000072
Chemical formula 4-2
Figure FDA0003523438570000081
Chemical formula 4-3
Figure FDA0003523438570000082
In the chemical formulas 4-1 to 4-3, R1 to R16 are defined as in chemical formula 1, and L1, L2, Ar1 and Ar2 are defined as in chemical formula 2.
7. The compound of claim 1, wherein said L1 and L2 are the same or different from each other and each is independently a direct bond or a phenylene group.
8. The compound of claim 1, wherein said Ar1 is a substituted or unsubstituted fluorenyl group and said Ar2 is a substituted or unsubstituted aryl group.
9. The compound of claim 1, wherein Ar1 and Ar2 are dimethylfluorenyl.
10. The compound of claim 1, wherein the chemical formula 1 is represented by any one of the following structural formulae:
Figure FDA0003523438570000091
Figure FDA0003523438570000101
Figure FDA0003523438570000111
Figure FDA0003523438570000121
Figure FDA0003523438570000131
Figure FDA0003523438570000141
Figure FDA0003523438570000151
Figure FDA0003523438570000161
Figure FDA0003523438570000171
11. an organic light emitting device, comprising: a first electrode, a second electrode, and 1 or more organic layers disposed between the first electrode and the second electrode, wherein 1 or more of the organic layers comprises the compound of any one of claims 1 to 10.
12. The organic light-emitting device according to claim 11, wherein the organic layer comprises a hole injection layer, a hole transport layer, or a hole injection and transport layer, and the hole injection layer, the hole transport layer, or the hole injection and transport layer contains the compound.
13. An organic light-emitting device according to claim 11 wherein the organic layer comprises a light-emission-assisting layer and the light-emission-assisting layer comprises the compound.
CN202080061153.0A 2019-11-14 2020-11-13 Compound and organic light emitting device including the same Pending CN114364678A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20190145641 2019-11-14
KR10-2019-0145641 2019-11-14
PCT/KR2020/015988 WO2021096285A1 (en) 2019-11-14 2020-11-13 Compound and organic light emitting device comprising same

Publications (1)

Publication Number Publication Date
CN114364678A true CN114364678A (en) 2022-04-15

Family

ID=75913092

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080061153.0A Pending CN114364678A (en) 2019-11-14 2020-11-13 Compound and organic light emitting device including the same

Country Status (3)

Country Link
KR (1) KR102542198B1 (en)
CN (1) CN114364678A (en)
WO (1) WO2021096285A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102786508A (en) * 2012-07-19 2012-11-21 南京邮电大学 Spiro-fluorene-9,9-xanthene bipolar luminescent material, its preparation method and its application method
CN107406391A (en) * 2015-09-30 2017-11-28 株式会社Lg化学 Spiro-compound and the organic illuminating element for including it

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014925B2 (en) * 2003-04-29 2006-03-21 Canon Kabushiki Kaisha Heterogeneous spiro compounds in organic light emitting device elements
CN103456897B (en) 2012-05-30 2016-03-09 京东方科技集团股份有限公司 Organic electroluminescence device
KR101849827B1 (en) * 2015-03-17 2018-04-17 주식회사 엘지화학 Organic light emitting device
CN107534091B (en) * 2015-06-19 2019-09-10 株式会社Lg化学 Organic luminescent device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102786508A (en) * 2012-07-19 2012-11-21 南京邮电大学 Spiro-fluorene-9,9-xanthene bipolar luminescent material, its preparation method and its application method
CN107406391A (en) * 2015-09-30 2017-11-28 株式会社Lg化学 Spiro-compound and the organic illuminating element for including it

Also Published As

Publication number Publication date
KR102542198B1 (en) 2023-06-12
WO2021096285A1 (en) 2021-05-20
KR20210058727A (en) 2021-05-24

Similar Documents

Publication Publication Date Title
JP6806312B2 (en) Organic light emitting element
CN112789273A (en) Novel compound and organic light emitting device comprising same
CN108699071B (en) Heterocyclic compound and organic electroluminescent element comprising same
CN110944991B (en) Heterocyclic compound and organic light emitting device including the same
KR102465732B1 (en) Novel compound and organic light emitting device comprising the same
CN113423706A (en) Novel compound and organic light emitting device comprising same
KR102531559B1 (en) Novel compound and organic light emitting device comprising the same
KR20220006313A (en) Anthracene compound, coating composition and organic light emitting device comprising same
CN113039183A (en) Novel compound and organic light emitting device comprising same
CN113166126A (en) Compound and organic light emitting device including the same
CN113195477A (en) Compound and organic light emitting device including the same
CN113195480A (en) Compound and organic light-emitting element comprising same
CN113166176A (en) Compound and organic light-emitting element comprising same
CN113166125B (en) Compound and organic light emitting device using the same
CN112204030B (en) Compound and organic light emitting device comprising the same
CN113056463B (en) Compound and organic light emitting device comprising the same
CN115867555A (en) Novel compound and organic light emitting device comprising same
CN114144402A (en) Novel compound and organic light emitting device comprising same
CN112771036A (en) Novel compound and organic light emitting device comprising same
CN113924666A (en) Organic light emitting device
KR20210152727A (en) Anthracene compound, coating composition and organic light emitting device comprising same
CN113166133A (en) Compound and organic light emitting device including the same
CN112789275A (en) Novel compound and organic light emitting device comprising same
CN113195478A (en) Compound and organic light emitting diode comprising same
CN113015728A (en) Novel compound and organic light emitting device using the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination